Brain Cancer Clinical Trials

Showing 701-720 of 1,466 trials

Stereotactic Radiosurgery in Treating Patients With Brain Tumors

NCT00019578

RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. PURPOSE: Phase I trial to study the effectiveness of stereotactic radiosurgery in treating patients who have brain tumors.

Adult Central Nervous System Germ Cell TumorAdult Malignant MeningiomaAdult Medulloblastoma+11 more

National Institutes of Health Clinical Center (CC)Started Nov 1998

Bethesda, Maryland, United States

UNKNOWNNA

Clinical Feasibility of Brain Radiotherapy Using Synthetic CTs in an MRI-only Workflow

NCT06106997

The goal of this observational study is to show the feasibility of an MRI-only workflow in brain radiotherapy. The main question it aims to answer is: * Is an MRI-only workflow based on deep learning sCTs feasible in clinical routine? Participants will be treated as in clinical routine, but treatment planning will be based on sCTs, that are generated from MRI images. The dosimetrical equivalence to the standard CT based workflow will be tested at several points in the study.

Brain Tumor, PrimaryBrain Tumor - Metastatic

University of Erlangen-Nürnberg Medical School54 participantsStarted Jan 2024

Erlangen, Germany

COMPLETEDNA

Mathematical Model-Adapted Radiation In Glioblastoma

NCT03557372

This research study is studying a new schedule of radiation therapy for recurrent glioblastoma as a possible treatment for this diagnosis. This radiation schedule is based on a new model for radiation resistance in glioblastoma. The name of the radiation schedule involved in this study is: \- Re-irradiation for glioblastoma using a novel Mathematical Model-Adapted Radiation Fractionation Schedule

Recurrent Glioblastoma

Dana-Farber Cancer Institute14 participantsStarted Nov 2018

Boston, Massachusetts, United States • Boston, Massachusetts, United States

Stereotactic Radiosurgery in Treating Patients With Brain Tumors

Clinical Feasibility of Brain Radiotherapy Using Synthetic CTs in an MRI-only Workflow

Mathematical Model-Adapted Radiation In Glioblastoma

Related Searches

Tumor Vaccines for Solid Tumors

Bevacizumab and Ascorbic Acid in Patients Treating With Recurrent High Grade Glioma

Entinostat in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors

Fast Brain MRI in Children With Suspected Brain Tumor

T-DM1 Alone Versus T-DM1 and Metronomic Temozolomide in Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases Following Stereotactic Radiosurgery

Safety and Efficacy of L19TNF Plus Temozolomide Chemoradiotherapy in Patients With Newly Diagnosed Glioblastoma

Determining Dose of Regadenoson Most Likely to Transiently Alter the Integrity of the Blood-Brain Barrier in Patients With High Grade Gliomas

Tislelizumab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for Bevacizumab Refractory Recurrent Glioblastoma

Evaluation of Changes in Brain Connectivity After Tumor Resection

The Effects of Using Different Anesthetics on the Prognosis of Primary Tumors and Its Mechanism of Action

Assessing the Effectiveness of 2D Non-Navigated Intraoperative Ultrasound in Glioma Surgery

Use of Pulsed Low-dose Rate Re-irradiation for Recurrent Glioma (PULSAR)

INC280 Combined With Bevacizumab in Patients With Glioblastoma Multiforme

Head and Neck Paragangliomas: A 16-year Experience of a University Hospital in Turkey

CAR T Cells to Target GD2 for DMG

Study of Laser Interstitial Thermal Therapy (LITT) Treatment Response Assessment With Fluciclovine PET MR

Coaching for Coping in Glioblastoma Patients and Caregivers and Its Association With Compliance to TTFields